Prostate cancer is perhaps the most important issue on which Movember’s different activities to raise awareness and funds and get people involved are centred.
If we stop for a moment to think about the impact of this disease all over the world, we will no doubt come to the conclusion that prostate cancer is one of the health problems to which we should all (medical and scientific community, national and international organisations and the general public) have greater commitment.
Some figures about prostate cancer
If we look at a country with a large population, such as the USA, prostate cancer is the second most common cancer in men, after skin cancer.
According to the American Cancer Society’s projections for 2014
– Almost 233,000 new cases will be diagnosed in the USA this year.
– The number of prostate cancer deaths could exceed 29,000.
– It affects all men, regardless of ethnicity. If we compare these figures with the data relating to 2011 when there were 209,292 new cases, we can see that the numbers have slightly increased.
There has also been a slight increase in the number of deaths compared to 2011 when 27,970 men died of prostate cancer in the USA.
In New Zealand, prostate cancer is the most common cancer in men, around 3,000 registrations each year and about 600 deaths from prostate cancer each year (based on the statistics from the Ministry of Health 2007 – 2009 which show an average of 3082 registrations and 602 deaths).
Movember has a plan against prostate cancer
This involves pooling efforts to achieve the best possible result. With this objective in mind, Movember has designed a Global Action Plan (GAP) the aims of which are to involve the best prostate cancer experts from all over the world in order to coordinate research and studies globally and to accelerate outcomes in the battle against the disease.
The Global Scientific Committee (GSC) is responsible for managing all the scientists involved in the GAP thanks to a top ranking team of people from some of the countries making most research progress in the subject:
- Pamela Russel (Australia)
- Rob Bristow (Canada)
- Jonathan Simons (USA)
- Hing Leung (UK)
- Jack Schaklken (Netherlands)
- William Watson (Ireland)
Another way Movember has contributed in the battle against prostate cancer is by creating an online knowledge exchange platform, called Promoveo. It is similar to any other type of online community or social network, but has been tailored specifically for the prostate cancer research scientists. Promeveo has many possibilities, which range from sharing ideas to locating major research resources available in other countries.
The key to Promoveo is also that it can be used as a discussion tool, helping research to make progress thanks to researchers from across the globe collaborating.
Best Doctors is convinced that one of the keys for the future of medicine lies in using new technology as a tool to connect and share knowledge globally.